Real-time enrollment status for this ebv-related hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: September 7, 2026 at 8:32 AM UTC
| NCT Number | NCT04664179 |
| Recruiting Status | Recruiting |
| Condition | EBV-Related Hodgkin Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 52 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Baylor College of Medicine |
| Last Updated on CT.gov | June 25, 2026 (Jun 25, 2026) |
As of September 7, 2026: Clinical trial NCT04664179 is currently recruiting participants. This phase1 study for ebv-related hodgkin lymphoma is actively seeking new participants at 4 locations across the United States. The study is sponsored by Baylor College of Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04664179 is actively recruiting participants as of September 7, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04664179 was last updated Jun 25, 2026 (June 25, 2026). HelloStudys verifies this status automatically.